Abstract:Amorphous indomethacin (IMC) prepared under different thermal procedures via melt quenching method showed significantly different dissolution behaviors. This study aims to investigate the influence of thermal procedures on the formation of IMC polyamorphism and to explore the mechanism for their different dissolution behaviors. Amorphous IMC samples were prepared by melting crystalline IMC under a series of temperatures (160-195 degrees C), respectively, followed by quenching in liquid nitrogen. Samples obtained under 170 degrees C exhibited bi-halo shapes at-15 degrees and-26 degrees (2 theta), while the ones above 175 degrees C showed a single halo at-21 degrees (2 theta), suggesting amorphous IMC prepared under different thermal procedures probably have different local molecular arrange-ments. In comparison to crystalline IMC, amorphous IMC obtained under 170 degrees C showed significantly higher dissolution profiles with good dispersibility in aqueous medium, however, all amorphous IMC samples prepared above 175 degrees C demonstrated much lower dissolution with significant gelation, which seemed like a gelation switch existed for polyamorphic IMC when the preparation temperature was between 170 and 175 degrees C. Based on physicochemical characterizations, amorphous IMC prepared under 170 degrees C had higher surface free energy, more surficial hydrophilic groups and better wettability than the ones made above 175 degrees C. Molecular dynamics simulations revealed that the amorphous samples prepared below 170 degrees C had similar binding energy values in the range of 310.045-325.479 kcal/mol, while those prepared above 175 degrees C were significantly lower within 212.193-235.073 kcal/mol. Such binding energy difference might be responsible for their different local mo-lecular arrangements after different thermal procedures. The current study deeply reminds us that the thermal procedure of preparation methods may significantly affect the physicochemical properties of amorphous mate-rials, which should be paid special attention to the polymorphic selection during pharmaceutical development.

Increasing the Dissolution Rate of A Low-Solubility Drug Through A Crystalline-Amorphous Transition: A Case Study with Indomethicin

Gel Formation Induced Slow Dissolution of Amorphous Indomethacin

Gelation Switch of Polyamorphic Indomethacin Depending on the Thermal Procedure.

A Method to Evaluate the Effect of Contact with Excipients on the Surface Crystallization of Amorphous Drugs

Quantification of crystallinity during indomethacin crystalline transformation from α- to γ-polymorphic forms and of the thermodynamic contribution to dissolution in aqueous buffer and solutions of solubilizer

Recrystallization Mediates the Gelation of Amorphous Drugs: the Case of Acemetacin

Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review

Bubble-induced fast crystal growth of indomethacin polymorphs in a supercooled liquid

The Effect of Cooling on the Degree of Crystallinity, Solid-State Properties, and Dissolution Rate of Multi-Component Hot-Melt Extruded Solid Dispersions

Mechanistic Insight into Gel-Induced Aggregation of Amorphous Curcumin During Dissolution Process.

Melt Crystallization of Indomethacin Polymorphs in the Presence of Poly(ethylene Oxide): Selective Enrichment of the Polymer at the Crystal-Liquid Interface.

Dissolution Of Crystalline Pharmaceuticals: Experimental Investigation And Thermodynamic Modeling

The Inherent AIE Feature Revealed the Drug Molecular State in Cyclodextrin Metal–organic Framework for Enhanced Stability and Absorption

Optimizing Nonsink Dissolution Testing for Amorphous Solid Dispersions: Exploring Sample Handling Variables

Crystallization Kinetics and Molecular Dynamics of Binary Coamorphous Systems of Nimesulide and Profen Analogs

Effect of Drug Loading in Mesoporous Silica on Amorphous Stability and Performance

Dry Amorphization of Itraconazole Using Mesoporous Silica and Twin-Screw Technology

Optimization of a Twin screw melt granulation process for fixed dose combination immediate release Tablets: Differential amorphization of one drug and crystalline continuance in the other

Combination of co-crystal and nanocrystal techniques to improve the solubility and dissolution rate of poorly soluble drugs

Spontaneous Crystalline-to-Amorphous Phase Transformation of Organic or Medicinal Compounds in the Presence of Porous Media, Part 3: Effect of Moisture

Hot Melt Extrusion Technology for Improved Dissolution, Solubility and "Spring-Parachute" Processes of Amorphous Self-Micellizing Solid Dispersions Containing BCS II Drugs Indomethacin and Fenofibrate: Profiles and Mechanisms.